News
5h
Capital Market on MSNPiramal Pharma to sell its decommissioned unit in MIDC, Thane for Rs 8.50 crPiramal Pharma announced that the Administrative Committee of the Board, at its meeting held today, has approved execution of ...
Piramal Pharma Limited announced that CARE Ratings Limited (CARE) has upgraded its long-term bank facilities rating and ...
Piramal Pharma Ltd, Anant Raj Ltd, TCI Express Ltd and Avadh Sugar & Energy Ltd will turn ex-date for dividends on Wednesday.
MUMBAI, India, March 31, 2021 /PRNewswire/ -- Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL ...
-Piramal Pharma Ltd. continúa invirtiendo en EE.UU.; 90 millones de dólares en la expansión de dos plantas en EE.UU. Adición de capacidades de producción de inyectables estériles a escala ...
Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through ...
MUMBAI, India, May 24, 2023 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31 st ...
MUMBAI, India, Oct. 23, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...
Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030. MUMBAI, India, Sept. 16, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a ...
MUMBAI, India, May 14, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness c. Tuesday, 02 January 2024 12:17 GMT.
MUMBAI, India, July 26, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated ...
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results